Gujarat Terce Laboratories Ltd Stock Analysis

BSE: 524314 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 23-Sep-2022 18:01
20.50 -0.70 (-3.30%)

DeciZen - Make an Informed Decision on Guj. Terce Lab

M-Cap below 100cr DeciZen not available

Guj. Terce Lab Price Chart

P/E Ratio (SA) :
Market Cap :
15.2 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Gujarat Terce Laboratories Ltd a good quality company?

Data is not available for this company.

2. Is Gujarat Terce Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Gujarat Terce Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Gujarat Terce Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gujarat Terce Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Guj. Terce Lab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

ROCE % 2.4%2.7%2%-2.2%1.2%2.4%5.5%3.8%-18.9%8.3%-
Value Creation Index -0.8-0.8-0.9-1.2-0.9-0.8-0.6-0.7-2.4-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 7928.926.52525.3293137.525.240.140
YoY Gr. Rt. %--63.5%-8.2%-5.6%1.2%14.7%7%21%-32.9%59.4%-
YoY Gr. Rt. %-28%-62.5%-858.3%NANA141.7%-36.2%-1100%NA-
BVPS (₹) 14.414.714.91413.61414.61510.311.59
Adj Net Profit
Cash Flow from Ops.
Debt/CF from Ops. 2.319644.1290.1-1.1-1.6-29-15.1-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -7.3%9.7%9%59.4%
Adj EPS 18.6%NA26%NA
BVPS -2.5-3.2-7.711.3
Share Price 5% 16.7% 48.9% 41.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity %
Op. Profit Mgn %
Net Profit Mgn %
Debt to Equity
Working Cap Days 792242472562462091961782711760
Cash Conv. Cycle 5012814515114694596098620

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.78

Sales growth is good in last 4 quarters at 36.16%

Return on Equity is Poor

Sales growth has been subdued in last 3 years 8.95%

Latest Financials - Gujarat Terce Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) -3.5 -
TTM Sales (₹ Cr.) 39.6 -
BVPS (₹.) 9 -
Reserves (₹ Cr.) -1 -
P/BV 2.29 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 12.78 / 43.40
All Time Low / High (₹) 0.50 / 49.95
Market Cap (₹ Cr.) 15.2
Equity (₹ Cr.) 7.4
Face Value (₹) 10
Industry PE 37.9

Management X-Ray of Guj. Terce Lab :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Guj. Terce Lab

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


About Gujarat Terce Laboratories Ltd

Gujarat Terce Laboratories is engaged in the manufacturing of tablets, capsules, syrup and injections pertaining to the product group, pharmaceutical formulations and ayurvedic medicines. The company is selling its product in the domestic as well as international market.

The company’s registered office and factory are located at Bileshwarpura, Gandhinagar in Gujarat. Installed capacity of the company is 270 million tablets and 108 million capsules per annum.

Product list of the company includes:

  • Tablets
  • Capsules
  • Syrup
  • Injections
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now